A recent meta-analysis published by Frontiers in Oncology has found a strong correlation between medical cannabis and its effectiveness in treating cancer-related symptoms. The study, led by the Whole Health Oncology Institute (WHOI) and powered by Cancer Playbook, aggregated data from over 10,000 peer-reviewed studies, surpassing any previous review in this field.
The meta-analysis showed that for every one study indicating cannabis was ineffective, there were three that demonstrated its benefits. This significant finding suggests a strong consensus among researchers, with the ratio of positive to negative results exceeding that of many FDA-approved medications.
Key benefits identified by the study include:
– Reduced cancer cell proliferation
– Inhibited metastasis, limiting cancer spread
– Increased apoptosis (natural cancer cell death)
– A profound anti-inflammatory effect
Cancer Playbook, a digital platform combining peer-reviewed research with patient-reported outcomes (PROs), has made this data available. The platform’s co-founder, Jim Gerencser, stated that “The science matters. But so does the patient.” He emphasized the importance of considering cannabis as a treatment option from the start, rather than waiting until traditional treatments have been exhausted.
By crowdsourcing real-world experiences and merging it with peer-reviewed research, Cancer Playbook aims to provide cancer patients with personalized, evidence-based insights. The platform’s mission is to disrupt outdated healthcare models and empower patients by putting actionable information directly in their hands.
Source: https://finance.yahoo.com/news/cancer-playbook-powered-whole-health-110200405.html